Apolipoprotein E Phenotype Alone Does Not Influence Survival in Alzheimer’s Disease: A Population-Based Longitudinal Study

Apolipoprotein E4 (ApoE4) phenotype is a known risk factor for development of Alzheimer’s disease (AD). Contradictory results exist concerning the role of ApoE4 in the rate of decline and mortality in AD. Conflicting findings have also been reported about ApoE and gender interactions with respect to...

Full description

Saved in:
Bibliographic Details
Published inNeuroepidemiology Vol. 19; no. 6; pp. 327 - 332
Main Authors Koivisto, Anne M., Lempiäinen, Päivi, Koivisto, Keijo, Helkala, Eeva-Liisa, Mykkänen, Leena, Kuusisto, Johanna, Kervinen, Kari, Kesäniemi, Y. Antero, Laakso, Markku, Soininen, Hilkka
Format Journal Article
LanguageEnglish
Published Basel, Switzerland S. Karger AG 01.11.2000
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Apolipoprotein E4 (ApoE4) phenotype is a known risk factor for development of Alzheimer’s disease (AD). Contradictory results exist concerning the role of ApoE4 in the rate of decline and mortality in AD. Conflicting findings have also been reported about ApoE and gender interactions with respect to survival. We examined the survival of subjects with AD and non-AD controls with respect to ApoE phenotype and gender in a population-based longitudinal study. Cognitive evaluation was performed for a total of 980 subjects (then aged 69–78 years), and 48 cases with AD were identified. ApoE4 phenotype was more frequently present among subjects with AD. In the whole study population, survival was not related to the presence of AD or ApoE4 phenotype. Risk of death was increased for men compared to women, independently of the ApoE4 phenotype (HR 0.5, 95% confidence interval 0.44–0.69). In subjects with AD, the presence of ApoE4 alone did not influence survival. However, in the AD group, ApoE4-negative men had significantly increased risk of mortality compared to the risk in ApoE4-negative women (p < 0.01). We conclude that the presence of ApoE4 phenotype or AD did not influence mortality in the aged population. Once AD had become manifest, ApoE4 alone did not relate to survival. However, in subjects with AD not carrying ApoE4, men had reduced survival compared to women.
AbstractList Apolipoprotein E4 (ApoE4) phenotype is a known risk factor for development of Alzheimer's disease (AD). Contradictory results exist concerning the role of ApoE4 in the rate of decline and mortality in AD. Conflicting findings have also been reported about ApoE and gender interactions with respect to survival. We examined the survival of subjects with AD and non-AD controls with respect to ApoE phenotype and gender in a population-based longitudinal study. Cognitive evaluation was performed for a total of 980 subjects (then aged 69-78 years), and 48 cases with AD were identified. ApoE4 phenotype was more frequently present among subjects with AD. In the whole study population, survival was not related to the presence of AD or ApoE4 phenotype. Risk of death was increased for men compared to women, independently of the ApoE4 phenotype (HR 0.5, 95% confidence interval 0.44-0.69). In subjects with AD, the presence of ApoE4 alone did not influence survival. However, in the AD group, ApoE4-negative men had significantly increased risk of mortality compared to the risk in ApoE4-negative women (p < 0.01). We conclude that the presence of ApoE4 phenotype or AD did not influence mortality in the aged population. Once AD had become manifest, ApoE4 alone did not relate to survival. However, in subjects with AD not carrying ApoE4, men had reduced survival compared to women.
Apolipoprotein E4 (ApoE4) phenotype is a known risk factor for development of Alzheimer's disease (AD). Contradictory results exist concerning the role of ApoE4 in the rate of decline and mortality in AD. Conflicting findings have also been reported about ApoE and gender interactions with respect to survival. We examined the survival of subjects with AD and non-AD controls with respect to ApoE phenotype and gender in a population-based longitudinal study. Cognitive evaluation was performed for a total of 980 subjects (then aged 69-78 years), and 48 cases with AD were identified. ApoE4 phenotype was more frequently present among subjects with AD. In the whole study population, survival was not related to the presence of AD or ApoE4 phenotype. Risk of death was increased for men compared to women, independently of the ApoE4 phenotype (HR 0.5, 95% confidence interval 0.44-0.69). In subjects with AD, the presence of ApoE4 alone did not influence survival. However, in the AD group, ApoE4-negative men had significantly increased risk of mortality compared to the risk in ApoE4-negative women (p &lt; 0.01). We conclude that the presence of ApoE4 phenotype or AD did not influence mortality in the aged population. Once AD had become manifest, ApoE4 alone did not relate to survival. However, in subjects with AD not carrying ApoE4, men had reduced survival compared to women.
Author Kuusisto, Johanna
Lempiäinen, Päivi
Koivisto, Anne M.
Koivisto, Keijo
Kervinen, Kari
Helkala, Eeva-Liisa
Kesäniemi, Y. Antero
Laakso, Markku
Mykkänen, Leena
Soininen, Hilkka
Author_xml – sequence: 1
  givenname: Anne M.
  surname: Koivisto
  fullname: Koivisto, Anne M.
– sequence: 2
  givenname: Päivi
  surname: Lempiäinen
  fullname: Lempiäinen, Päivi
– sequence: 3
  givenname: Keijo
  surname: Koivisto
  fullname: Koivisto, Keijo
– sequence: 4
  givenname: Eeva-Liisa
  surname: Helkala
  fullname: Helkala, Eeva-Liisa
– sequence: 5
  givenname: Leena
  surname: Mykkänen
  fullname: Mykkänen, Leena
– sequence: 6
  givenname: Johanna
  surname: Kuusisto
  fullname: Kuusisto, Johanna
– sequence: 7
  givenname: Kari
  surname: Kervinen
  fullname: Kervinen, Kari
– sequence: 8
  givenname: Y. Antero
  surname: Kesäniemi
  fullname: Kesäniemi, Y. Antero
– sequence: 9
  givenname: Markku
  surname: Laakso
  fullname: Laakso, Markku
– sequence: 10
  givenname: Hilkka
  surname: Soininen
  fullname: Soininen, Hilkka
BackLink https://www.ncbi.nlm.nih.gov/pubmed/11060507$$D View this record in MEDLINE/PubMed
BookMark eNqFkcFu1DAQhi1URLeFA2ckZHFA4hAY23HicAvdpa20KpUK58hNJq2L1w52UmlRD30NXo8nqemuWgkhMRfPWN_8v0b_Htlx3iEhLxm8Z0xWHyAVL3jJn5AZy7nIgIPaITPgkmVSSNglezFeASRYVc_ILmNQgIRyRm7qwVsz-CH4EY2jC3p6ic6P6wFpbZMNnXuM9MSP9Nj1dkLXIj2bwrW51pamhdr-vESzwvD79lekcxNRR_xIa3rqh8nq0XiXfUpfHV16d2HGqTMubZ6lZv2cPO21jfhi--6Tb58XXw-OsuWXw-ODepm1QhVj1uZ9X_WtgIKJHAAl5sCQCQEgpOhyrnutsJdMQKU4qvwcqrZQrGCyy9Mo9snbjW668seEcWxWJrZorXbop9iUXFQc8uq_ICtVqZgSCXzzF3jlp5AOiw0XvCpKUDxB7zZQG3yMAftmCGalw7ph0PwJrnkILrGvt4LT-Qq7R3Kb1KPjdx0uMDwAJ4v5vUIzdH2CXv0T2njcAQlEqJ4
CitedBy_id crossref_primary_10_1089_rej_2011_1169
crossref_primary_10_1016_j_neurobiolaging_2007_12_003
crossref_primary_10_1093_gerona_gls192
crossref_primary_10_1212_01_WNL_0000118210_12660_C2
crossref_primary_10_1212_01_wnl_0000334278_11022_42
crossref_primary_10_1007_s11357_010_9144_x
crossref_primary_10_1002_gps_2039
crossref_primary_10_1093_gerona_glad168
crossref_primary_10_1002_gps_371
crossref_primary_10_1212_01_wnl_0000277320_50685_7c
crossref_primary_10_1016_j_neulet_2005_08_002
crossref_primary_10_1212_WNL_59_7_1034
crossref_primary_10_1016_j_jalz_2011_12_004
crossref_primary_10_1007_s10654_007_9202_6
crossref_primary_10_1159_000068779
crossref_primary_10_1212_WNL_58_7_1045
crossref_primary_10_1212_01_wnl_0000188871_74093_12
Cites_doi 10.1001/jama.272.21.1666
ContentType Journal Article
Copyright 2000 S. Karger AG, Basel
Copyright 2000 S. Karger AG, Basel
Copyright S. Karger AG Nov/Dec 2000
Copyright_xml – notice: 2000 S. Karger AG, Basel
– notice: Copyright 2000 S. Karger AG, Basel
– notice: Copyright S. Karger AG Nov/Dec 2000
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7TK
7U7
7U9
7X7
7XB
88E
88G
88I
8AF
8AO
8C1
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
C1K
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
M0S
M1P
M2M
M2P
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
S0X
7X8
DOI 10.1159/000026272
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Neurosciences Abstracts
Toxicology Abstracts
Virology and AIDS Abstracts
Proquest Health and Medical Complete
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
Science Database (Alumni Edition)
STEM Database
ProQuest Pharma Collection
Public Health Database (Proquest)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
AUTh Library subscriptions: ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection (Proquest) (PQ_SDU_P3)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Psychology Journals (ProQuest)
ProQuest Science Journals
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
SIRS Editorial
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest One Psychology
ProQuest Central Student
ProQuest Central Essentials
SIRS Editorial
ProQuest Health & Medical Complete (Alumni)
ProQuest AP Science
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Pharma Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
AIDS and Cancer Research Abstracts
ProQuest Medical Library (Alumni)
ProQuest Public Health
Virology and AIDS Abstracts
ProQuest Science Journals (Alumni Edition)
ProQuest Central Basic
Toxicology Abstracts
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest One Psychology
Neurosciences Abstracts

MEDLINE - Academic
MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: AUTh Library subscriptions: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 1423-0208
EndPage 332
ExternalDocumentID 63579558
10_1159_000026272
11060507
26272
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Finland
GeographicLocations_xml – name: Finland
GroupedDBID ---
0R~
0~5
0~B
123
29N
30W
325
36B
3O.
3V.
4.4
53G
5RE
7X7
88E
88I
8AF
8AO
8C1
8FI
8FJ
8UI
AAYIC
ABIVO
ABJNI
ABPAZ
ABUWG
ACGFS
ACGOD
ACPRK
ACPSR
ADAGL
ADBBV
ADGES
AENEX
AEYAO
AFJJK
AFKRA
AFRAH
AHMBA
ALDHI
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AZPMC
AZQEC
BENPR
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
CYUIP
DU5
DWQXO
E0A
EBS
EJD
EMOBN
F5P
FB.
FYUFA
GNUQQ
HCIFZ
HMCUK
HZ~
IAO
IHR
IHW
IY7
KUZGX
M1P
M2M
M2P
N9A
O1H
O9-
P2P
PQQKQ
PROAC
PSQYO
PSYQQ
RIG
RKO
RXVBD
S0X
UJ6
UKHRP
YHZ
ZGI
CGR
CUY
CVF
ECM
EIF
ITC
NPM
AAYXX
CITATION
7TK
7U7
7U9
7XB
8FK
C1K
H94
K9.
PQEST
PQUKI
PRINS
Q9U
7X8
ID FETCH-LOGICAL-c386t-c4ff9fc30613400e5e401e13300353d42afa8ef5130982e84b09c681615d4e843
IEDL.DBID 8C1
ISSN 0251-5350
IngestDate Fri Aug 16 23:23:00 EDT 2024
Fri Aug 16 09:34:31 EDT 2024
Thu Oct 10 22:13:17 EDT 2024
Thu Sep 26 16:27:28 EDT 2024
Sat Sep 28 07:36:56 EDT 2024
Thu Aug 29 12:04:22 EDT 2024
Thu Sep 05 17:58:07 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Gender
Apolipoprotein E
Survival
Alzheimer's disease
Mortality
Language English
License Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Copyright 2000 S. Karger AG, Basel
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c386t-c4ff9fc30613400e5e401e13300353d42afa8ef5130982e84b09c681615d4e843
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
PMID 11060507
PQID 232967082
PQPubID 32897
PageCount 6
ParticipantIDs proquest_miscellaneous_72392049
proquest_miscellaneous_17878183
crossref_primary_10_1159_000026272
proquest_journals_232967082
karger_primary_26272
pubmed_primary_11060507
PublicationCentury 2000
PublicationDate 2000-11-01
PublicationDateYYYYMMDD 2000-11-01
PublicationDate_xml – month: 11
  year: 2000
  text: 2000-11-01
  day: 01
PublicationDecade 2000
PublicationPlace Basel, Switzerland
PublicationPlace_xml – name: Basel, Switzerland
– name: Switzerland
– name: Basel
PublicationTitle Neuroepidemiology
PublicationTitleAlternate Neuroepidemiology
PublicationYear 2000
Publisher S. Karger AG
Publisher_xml – name: S. Karger AG
References Mykkänen L, Laakso M, Uusitupa M, Pyörälä K: Prevalence of diabetes and impaired glucose tolerance in elderly subjects and their association with obesity and family history of diabetes. Diabetes Care 1990;11:1099-1105.
Drachman DA, O'Donnel BF, Lew RA, Swearer JM: The prognosis in Alzheimer's disease. 'How far' rather than 'how fast' best predicts the course. Arch Neurol 1990;47:851-856.2375690
Wolf PA, Cobb JL, D'Agostino RB: Epidemiology of Stroke; in Barnet HJM, Mohr JP, Stein BM, Yatsy FM (eds): Stroke. Pathophysiology, diagnosis, and management, ed 2. New York, Churchill Livingstone, 1992, pp 3-27.
Cox DR: Regression models and life-tables. J R Stat Soc 1972;34:187-201.
Olichney JM, Sabbagh MN, Hofstetter CR, Galasko D, Grundman M, Katzman R, Thal LJ: The impact of apolipoprotein E4 on cause of death in Alzheimer's disease. Neurology 1997;49:76-81.9222173
Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM, for the APOE and Alzheimer's Disease Meta Analysis Consortium: Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: A meta-analysis. JAMA 1997;278:1349-1356.9343467
Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC Jr, Rimmler JB, Locke PA, Coneally PM, Schmader KE, Tanzi RE, Gusella JF, Small GW, Roses AD, Pericak-Vance MA, Haines JL: Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology 1995;45:1323-1328.7617191
Kuusisto J, Koivisto K, Kervinen K, Mykkänen L, Helkala E-L, Vanhanen M, Hänninen T, Pyörälä K, Kesäniemi YA, Riekkinen P, Laakso M: Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: Population based study. BMJ 1994;309:636-638.8086986
Stern Y, Brandt J, Albert M, Jacobs DM, Liu X, Bell K, Marder K, Sano M, Albert S, Del-Castillo Castaneda C, Bylsma F, Tycko B, Mayeux R: The absence of an apolipoprotein 4 allele is associated with a more aggressive form of Alzheimer's disease. Ann Neurol 1997;41:615-620.9153523
Craft S, Teri L, Edland SD, Kukull WA, Schellenberg G, McCormick WC, Bowen JD, Larson EB: Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease. Neurology 1998;51:149-153.9674794
Slooter AJ, Houwing-Duistermaat JJ, van Harskamp F, Cruts M, Van Broeckhoven C, Breteler MMB, Hofman A, Stijnen T, van Duijn CM: Apolipoprotein E genotype and progression of Alzheimer's disease. The Rotterdam Study. J Neurol 1999;246:304-308.10367700
Growdon JH, Locascio JJ, Corkin S, Gomez-Isla T, Hyman BT: Apolipoprotein E genotype does not influence rates of cognitive decline. Neurology 1996;47:444-448.8757018
Wilson PWF, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ: Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA 1994;272:1666-1671.796689410.1001/jama.272.21.1666
Tilvis RS, Strandberg TE, Juva K: Apolipoprotein E phenotypes, dementia and mortality in a prospective population sample. J Am Geriatr Soc 1998;46:712-715.9625186
ref1
References_xml – ident: ref1
  doi: 10.1001/jama.272.21.1666
SSID ssj0015989
Score 1.7158312
Snippet Apolipoprotein E4 (ApoE4) phenotype is a known risk factor for development of Alzheimer’s disease (AD). Contradictory results exist concerning the role of...
Apolipoprotein E4 (ApoE4) phenotype is a known risk factor for development of Alzheimer's disease (AD). Contradictory results exist concerning the role of...
SourceID proquest
crossref
pubmed
karger
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 327
SubjectTerms Aged
Alzheimer Disease - genetics
Alzheimer Disease - mortality
Apolipoproteins E - genetics
Catchment Area (Health)
Cognition Disorders - diagnosis
Cohort Studies
Female
Finland - epidemiology
Follow-Up Studies
Humans
Male
Neuropsychological Tests
Original Paper
Population Surveillance
Survival Rate
Title Apolipoprotein E Phenotype Alone Does Not Influence Survival in Alzheimer’s Disease: A Population-Based Longitudinal Study
URI https://karger.com/doi/10.1159/000026272
https://www.ncbi.nlm.nih.gov/pubmed/11060507
https://www.proquest.com/docview/232967082
https://search.proquest.com/docview/17878183
https://search.proquest.com/docview/72392049
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS9xAEB_qB0UQabXqqb0uUujT0kt2N5v4IqeeSMFDpMK9hXxs2kNN4uXuxb_emc1epAV9zGxIlp2P3-zO7AzA94FOgiDNPa4NapNMvYyHJlA8NZ4wflTI3LZOuB4HV3fy10RNXG5O49IqlzbRGuq8yuiM_CcifxRoBKzT-olT0ygKrroOGiuw5iHMUUZfeN5leCBQ2w545EVzJdTAFRZCuq3Z6Ae-9v-Bo_V7yr6eve1sWtC5_ARbzltkw5a9n-GDKbfh47WLh2_DZnvqxtrLRDvwPKSmC3Vlqy9MSzZilMJV0TkrSx6q0rC8Mg1DCpsuu5OwZoHmAgUOSWz48PzXTB_N7EfDXOzmhA1Z3bX54gR7OcNv_ZlSCiJNz5ao_QJ3l6Pf51fcdVfgmQiDOc9kUURFJgjQUZGNMrjVQg4JCi4KZFFSJKEpFIJcFPomlOkgyoKQPMRc4qPYhdUSJ74PTBQqVxT_09JIKRNkf0hCkAqlEylkD46XixzXbRGN2G4-VBR3nOjBTrv83SuOfPgfeTy6sCNxnRc4umRV7JSviTtR6cG3bhS1hkIhSWmqRRN7aKfQVRFvv6F99Bxx-9SDvVYCXmeOu-gButEH7_77EDbsrX17bfEIVuezhfmK_ss87cOKnui-ldU-rJ2Nxje3L3aB708
link.rule.ids 315,783,787,12068,12235,21400,27936,27937,31731,31732,33278,33279,33756,33757,43322,43591,43817,74073,74342,74630
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED9BQWMSQtCNrQyYhZD2ZK2N7XzsZapGqwJtn1qpb1E-nK2iJFnTvvSv353jZhrSeMw5Sizfne_Od74fwPeuF7lunPa4p1GbZNxLuK9dxWPdE9oJMpka6ITJ1B3N5a-FWtjanMqWVe73RLNRp0VCZ-SXaPkD10ODdV3ecwKNouSqRdB4Ca-oDRcBGHiLJt5CQ20Q8MiL5kqorm0shHTTs9FxHc95Yo5e_6Hq6_XzzqYxOsP38M56i6xfs_cDvNB5Gw4mNh_ehrf1qRurLxMdwa5PoAtlYbovLHM2YFTCVdA5K4tWRa5ZWuiKIYUt9-gkrNridoEChyTWX-3u9PKvXl9UzOZurliflQ3MFyezlzL81u2SShBpeqZF7THMh4PZzYhbdAWeCN_d8ERmWZAlggw6KrJWGkMt5JCg5KJAFkVZ5OtMoZELfEf7Mu4GieuTh5hKfBQfoZXjxE-BiUylivJ_ntRSygjZ75MQxEJ5kRSyA9_2ixyWdRON0AQfKggbTnTgqF7-5hVLPvuHPB38MCNhmWY4umdVaJWvChtR6cB5M4paQ6mQKNfFtgp7uE-hqyKef8Nz0HPE8KkDJ7UEPM4co-guutGf_vvvc3gzmk3G4fjn9PcZHJob_OYK42dobdZb_QV9mU381UjsA_os7-0
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEB_0KkUQ0dbq2WoXEXxamst-JOmLXNs76kePIhb6FvKx2x7WJF7uXvrXd2azF7FQHzMbkmXnc3dm5wfwMYgyrfNyxCOD2iTzUcFjoxXPzUiYMLGydNAJZzN9eiG_XqpL31Ko9WWVa5voDHVZF3RGfoCeP9EROqwD66sizk-mn5s_nACkKNHq0TQew0YktQgGsHE0mZ3_6FMKKnF4eBRTcyVU4NsMId11cAx1GIX_OKcnv6gWe_Fw6Olc0PQFPPexIxt3zH4Jj0y1BZtnPju-Bc-6MzjWXS3ahtsxQTA0tevFMK_YhFFBV02nriy7qSvDytq0DClsvsYqYe0KjQeKH5LY-Ob22sx_m8WnlvlMziEbs6YH_eLkBEuG37qaU0EiTc81rH0FF9PJz-NT7rEWeCFiveSFtDaxhSD3jmptlMGNF_JLUKpRIMMym8XGKnR5SRyaWOZBUuiY4sVS4qPYgUGFE38DTFhVKsoGRtJIKTMUhphEIhcqyqSQQ_iwXuS06VpqpG4ropK058QQtrvl71_x5N175NnkxI2kTWlxdM2q1Ktim_aCM4T9fhR1iBIjWWXqVZuO0Gph4CIefiMKMY7EzdQQXncS8HfmuKcOMKh--99_78Mmimv6_cvs2y48ddf53X3GPRgsFyvzDgObZf7ei-wdcir1ig
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Apolipoprotein+E+Phenotype+Alone+Does+Not+Influence+Survival+in+Alzheimer%E2%80%99s+Disease%3A+A+Population-Based+Longitudinal+Study&rft.jtitle=Neuroepidemiology&rft.au=Koivisto%2C+Anne+M.&rft.au=Lempi%C3%A4inen%2C+P%C3%A4ivi&rft.au=Koivisto%2C+Keijo&rft.au=Helkala%2C+Eeva-Liisa&rft.date=2000-11-01&rft.issn=0251-5350&rft.eissn=1423-0208&rft.volume=19&rft.issue=6&rft.spage=327&rft.epage=332&rft_id=info:doi/10.1159%2F000026272&rft.externalDBID=n%2Fa&rft.externalDocID=10_1159_000026272
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0251-5350&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0251-5350&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0251-5350&client=summon